![Glenn A. Hopkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn A. Hopkins
Direktor/Vorstandsmitglied bei
RHEI Pharmaceuticals, Inc.
Profil
Glenn A. Hopkins is currently a Director at RHEI Pharmaceuticals, Inc. Prior to his current position, he worked as a Principal at Thomas H.
Lee Partners LP from 1989 to 1994 and as a Partner at Prospect Hill Growth Partners LP from 1995 to 2014.
Hopkins received his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Aktive Positionen von Glenn A. Hopkins
| Unternehmen | Position | Beginn |
|---|---|---|
RHEI Pharmaceuticals, Inc.
 RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Glenn A. Hopkins
| Unternehmen | Position | Ende |
|---|---|---|
Thomas H. Lee Partners LP
 Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Corporate Officer/Principal | 31.12.1994 |
Prospect Hill Growth Partners LP
 Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Corporate Officer/Principal | - |
Ausbildung von Glenn A. Hopkins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Thomas H. Lee Partners LP
Thomas H. Lee Partners LP Investment ManagersFinance Thomas H Lee Partners invests in middle market companies located in the United States. The firm targets companies operating in the fields of financial technology & services, healthcare, technology & business solutions and automation sectors. It provides financing for growth, acquisitions, recapitalizations and buyout stage capital transactions. | Finance |
Prospect Hill Growth Partners LP
Prospect Hill Growth Partners LP Investment ManagersFinance Prospect Hill Growth Partners invests in middle-market growth companies located in North America with revenues of USD 50 - 300 million and EBITDA of USD 5 - 25 million. The firm focuses on the consumer and healthcare strategy sectors. It participates in buyout transactions with an investment size of USD 25 - 100 million. It also makes co-investments. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, licenses, develops and commercializes therapies | Health Technology |
Wählen Sie MarketScreener 
